Manipulating the immune system: humoral versus cell-mediated immunity

Area of Science:

• Vaccinology
• Immunology
• Infectious Diseases

Background:

• Traditional vaccines often lack mechanistic understanding and can cause side effects.
• Newer vaccines (recombinant proteins, DNA) are safer but may have low immunogenicity, especially via mucosal routes.
• Oral vaccine delivery requires high antigen doses for minimal immune response.

Purpose of the Study:

• To explore rational design of safe and effective mucosal vaccines.
• To investigate the potential of nasal vaccine delivery systems.
• To leverage advances in T helper cell (Th1/Th2) immunology for vaccine development.

Main Methods:

• Review of existing vaccine design principles and limitations.
• Analysis of immune responses elicited by different antigen delivery routes (oral vs. nasal).
• Examination of the role of adjuvants and immunomodulators in directing T cell responses.

Main Results:

• Nasal antigen delivery with adjuvants generates potent immune responses in animal models.
• Nasal delivery offers a more effective route for mucosal vaccination compared to oral delivery.
• Understanding Th1/Th2 immune pathways allows for targeted vaccine design.

Conclusions:

• Rationally designed mucosal vaccines can overcome limitations of current approaches.
• Adjuvants and immunomodulators are key to inducing protective T cell immunity.
• Nasal delivery is a promising strategy for developing effective vaccines against infectious diseases.